Company Overview and News

 
Aura Energy shares rise as it advances vanadium spin-out and IPO plan

2018-04-19 proactiveinvestors.com.au
Aura Energy Limited (LON:AURA) shares advanced as the company updated investors on plans to spin out its Swedish vanadium operation.
Upvote Downvote

 
Aura Energy secures funds for vanadium project, shares rise

2018-03-29 proactiveinvestors.com.au
Aura Energy Ltd (ASX:AEE) (LON:AURA) has completed a heavily oversubscribed capital raising priced at 1.9 cents which has secured $3.7 million in funding.
Upvote Downvote

 
Uranium shares spike as Canadian giant Cameco suspends production

2017-11-09 theage.com.au
The uranium price slump has forced the world's largest producer, Cameco, to temporarily suspend production at two key operations from next year, driving Australian uranium miners' shares skywards.
Upvote Downvote

 
Uranium shares spike as Canadian giant Cameco suspends production

2017-11-09 smh.com.au
The uranium price slump has forced the world's largest producer, Cameco, to temporarily suspend production at two key operations from next year, driving Australian uranium miners' shares skywards.
Upvote Downvote

 
Aura Energy pauses trade to lift funds for uranium and polymetallic projects

2017-10-31 proactiveinvestors.com.au
Aura Energy Ltd (ASX:AEE,LON:AURA) maintains a clear strategy to advance the Tiris Uranium Project into production 2019, which is located in Mauritania.
Upvote Downvote

 
Aura Energy secures approval for uranium project

2017-10-06 australianmining.com.au
Aura Energy has received environmental approval by the Mauritian Government for its Tiris uranium project in Reguibat.
Upvote Downvote

 
Aura Energy secures approval for uranium project

2017-10-06 australianmining.com.au
Aura Energy has received environmental approval by the Mauritian Government for its Tiris uranium project in Reguibat.
Upvote Downvote

 
June Quarterly Report

2017-07-31 londonstockexchange
To view this release as a .pdf complete with referenced images please click the following link:  http://www.auraenergy.com.au/announcements-2017.html
Upvote Downvote

 
Why Is Ameren (AEE) Up 3.6% Since the Last Earnings Report?

2017-06-08 zacks
A month has gone by since the last earnings report for Ameren Corporation (AEE - Free Report) . Shares have added about 3.6% in that time frame, outperforming the market.
Upvote Downvote

 
Ameren (AEE) Overvalued than Industry, Should You Sell?

2017-05-25 zacks
We issued an updated research report on Ameren Corporation (AEE - Free Report) on May 22. The company started off 2017 on a mixed note. While first-quarter earnings declined year over year,  revenues increased significantly. On the other hand, cash from operating activities decreased from the prior-year quarter.
Upvote Downvote

 
Tiris Mining Lease Application Submitted

2017-05-24 londonstockexchange
The original release includes pictures from the Tiris Project Community Consultation Days To view the original complete with images please see the Aura Energy website: http://www.auraenergy.com.au/announcements-2017.html
Upvote Downvote

 
Quarterly Report

2017-04-28 londonstockexchange
To view this release as a .pdf complete with referenced images please click the following link:
Upvote Downvote

 
Tiris Feasibility Study Update

2017-04-26 londonstockexchange
Aura Energy Limited (AEE; ASX, AURA; AIM) is pleased to advise that the various elements of the Tiris Definitive Feasibility Study (“DFS”) continue to progress strongly, with activity in all the principal areas of the study.
Upvote Downvote

 
Strong Hippolyte South Uranium Survey

2017-04-19 londonstockexchange
To view this release as a .pdf complete with referenced images please click the following link:
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

11h - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...